CXCL10 and COVID-19: Hence, by analyzing both the ACE2 receptor and the CXCL10 chemokine in terms of expression, the nature of COVID-19 in lung cancer patients can be highlighted and understood at a comprehensive level and questions- why a certain cancer cohort is more susceptible to COVID-19 can be addressed.